64 related articles for article (PubMed ID: 21609895)
1. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancer.
Giron-Michel J; Azzi S; Khawam K; Caignard A; Devocelle A; Perrier A; Chouaib S; Eid P; Azzarone B
Bull Cancer; 2011 May; 98(5):32-9. PubMed ID: 21609895
[TBL] [Abstract][Full Text] [Related]
2. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.
Giron-Michel J; Azzi S; Khawam K; Mortier E; Caignard A; Devocelle A; Ferrini S; Croce M; François H; Lecru L; Charpentier B; Chouaib S; Azzarone B; Eid P
PLoS One; 2012; 7(2):e31624. PubMed ID: 22363690
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis.
Giron-Michel J; Azzi S; Ferrini S; Chouaib S; Camussi G; Eid P; Azzarone B
Cytokine Growth Factor Rev; 2013 Feb; 24(1):13-22. PubMed ID: 22981349
[TBL] [Abstract][Full Text] [Related]
5. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.
Chuang MJ; Sun KH; Tang SJ; Deng MW; Wu YH; Sung JS; Cha TL; Sun GH
Cancer Sci; 2008 May; 99(5):905-13. PubMed ID: 18294286
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
[TBL] [Abstract][Full Text] [Related]
9. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
Obiri NI; Husain SR; Debinski W; Puri RK
Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
[TBL] [Abstract][Full Text] [Related]
12. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
13. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific interleukin-15 and interleukin-15 receptor subunit expression and regulation in pneumococcal pneumonia--comparison to chlamydial lung infection.
Hocke AC; Lampe MP; Witzenrath M; Mollenkopf H; Zerrahn J; Schmeck B; Kessler U; Krüll M; Hammerschmidt S; Hippenstiel S; Schütte H; Suttorp N; Rosseau S
Cytokine; 2007 May; 38(2):61-73. PubMed ID: 17611121
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
19. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
Rissanen J; Korhonen M; Lehto VP; Virtanen I
J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
